Paolino, G.; Ramirez, G.A.; Calabrese, C.; Moroni, L.; Bianchi, V.G.; Bozzolo, E.P.; Mercuri, S.R.; Dagna, L.
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature. Biomedicines 2023, 11, 2904.
https://doi.org/10.3390/biomedicines11112904
AMA Style
Paolino G, Ramirez GA, Calabrese C, Moroni L, Bianchi VG, Bozzolo EP, Mercuri SR, Dagna L.
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature. Biomedicines. 2023; 11(11):2904.
https://doi.org/10.3390/biomedicines11112904
Chicago/Turabian Style
Paolino, Giovanni, Giuseppe A. Ramirez, Chiara Calabrese, Luca Moroni, Vittoria Giulia Bianchi, Enrica P. Bozzolo, Santo Raffaele Mercuri, and Lorenzo Dagna.
2023. "Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature" Biomedicines 11, no. 11: 2904.
https://doi.org/10.3390/biomedicines11112904
APA Style
Paolino, G., Ramirez, G. A., Calabrese, C., Moroni, L., Bianchi, V. G., Bozzolo, E. P., Mercuri, S. R., & Dagna, L.
(2023). Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature. Biomedicines, 11(11), 2904.
https://doi.org/10.3390/biomedicines11112904
